BR1100311A - Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica - Google Patents

Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica

Info

Publication number
BR1100311A
BR1100311A BR1100311-1A BR1100311A BR1100311A BR 1100311 A BR1100311 A BR 1100311A BR 1100311 A BR1100311 A BR 1100311A BR 1100311 A BR1100311 A BR 1100311A
Authority
BR
Brazil
Prior art keywords
pct
antimitotic
alkaloids
medication
binary
Prior art date
Application number
BR1100311-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Jean-Claude Jacquesy
Jacques Fahy
Christian Berrier
Dennis Bigg
Marie Paule Jouannetaud
Fabien Zunino
Anna Kruczynski
Robert Kiss
Original Assignee
Jean-Claude Jacquesy
Jacques Fahy
Christian Berrier
Dennis Bigg
Marie Paule Jouannetaud
Fabien Zunino
Anna Kruczynski
Robert Kiss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9449457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100311(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jean-Claude Jacquesy, Jacques Fahy, Christian Berrier, Dennis Bigg, Marie Paule Jouannetaud, Fabien Zunino, Anna Kruczynski, Robert Kiss filed Critical Jean-Claude Jacquesy
Publication of BR1100311A publication Critical patent/BR1100311A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR1100311-1A 1993-07-21 1997-04-22 Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica BR1100311A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308948A FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.

Publications (1)

Publication Number Publication Date
BR1100311A true BR1100311A (pt) 1999-08-31

Family

ID=9449457

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100311-1A BR1100311A (pt) 1993-07-21 1997-04-22 Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica

Country Status (15)

Country Link
US (1) US5620985A (enExample)
EP (1) EP0710240B1 (enExample)
JP (1) JP3606872B2 (enExample)
AT (1) ATE146477T1 (enExample)
AU (1) AU693460B2 (enExample)
BR (1) BR1100311A (enExample)
CA (1) CA2167694C (enExample)
DE (2) DE122010000012I1 (enExample)
DK (1) DK0710240T3 (enExample)
ES (1) ES2097659T3 (enExample)
FR (2) FR2707988B1 (enExample)
GR (1) GR3022659T3 (enExample)
LU (1) LU91660I2 (enExample)
NZ (2) NZ269172A (enExample)
WO (1) WO1995003312A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737208A1 (fr) * 1995-07-28 1997-01-31 Pf Medicament Nouvelles fluorovindolines, precurseurs d'analogues de la vinblastine et de la vinorelbine,leurs procedes de preparation et leur utilisation comme medicament
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
FR2783522A1 (fr) * 1998-09-21 2000-03-24 Pf Medicament Composes derives d'alcaloides de vinca, leur preparation et leur application en therapeutique
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
EP1694330A4 (en) 2003-12-04 2009-06-24 Amr Technology Inc DERIVATIVES OF VINORELBINE
JP5448299B2 (ja) 2003-12-04 2014-03-19 アルバニー モレキュラー リサーチ, インコーポレイテッド ビンカ誘導体
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
DE602005027673D1 (de) * 2004-03-05 2011-06-09 Vegenics Pty Ltd Materialien und verfahren für wachstumsfaktorbindende konstrukte
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
EP1989212B1 (en) 2006-02-17 2013-06-19 Cascade Prodrug Inc. Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
CN101108859A (zh) * 2006-07-17 2008-01-23 上海恒瑞医药有限公司 长春碱类化合物、其制备方法及其在医药上的用途
WO2008033935A2 (en) * 2006-09-12 2008-03-20 Amr Technology, Inc. Vinorelbine derivatives
WO2008033930A2 (en) * 2006-09-12 2008-03-20 Amr Technology, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
CN101235046B (zh) * 2007-01-29 2010-09-08 中国科学院上海药物研究所 长春碱衍生物、其制备方法和用途、以及包含该衍生物的药物组合物
FR2912406B1 (fr) 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (en) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Cancer treatment combination therapy comprising vinflunine and trastuzumab
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
EP2376515A1 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthesis of purine nucleosides
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
WO2011116026A2 (en) 2010-03-15 2011-09-22 The Board Of Trustees Of The University Of Illinois Inhibitors of beta integrin-g protein alpha subunit binding interactions
CL2011000718A1 (es) 2010-03-31 2012-04-09 Gilead Pharmasset Llc Proceso para la preparacion de compuestos fosforados enantiomericos.
EP2655401B1 (en) 2010-12-20 2016-03-09 The Regents of the University of Michigan Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
CN103788117A (zh) * 2012-10-30 2014-05-14 何小解 一种脱水长春碱、长春瑞滨及长春氟宁连续化合成工艺
HU230462B1 (hu) 2013-05-30 2016-07-28 Richter Gedeon Nyrt. Új bisz-indol alkaloidok mint rákellenes gyógyszerek
WO2015107119A1 (en) 2014-01-15 2015-07-23 Centre National De La Recherche Scientifique (Cnrs) Water soluble 4-azapodophyllotoxin analogs
JP7264592B2 (ja) 2015-01-26 2023-04-25 ザ ユニバーシティー オブ シカゴ IL13Rα2結合剤及び癌治療におけるその使用
WO2016123143A1 (en) 2015-01-26 2016-08-04 The University Of Chicago CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Rα2
JP2019508436A (ja) * 2016-03-09 2019-03-28 シンバイアス ファーマ アー・ゲー ビノレルビンモノタルトラートおよびその薬学的使用
US20190307741A1 (en) 2016-07-06 2019-10-10 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination
MX2020001451A (es) 2017-08-07 2020-08-06 Amgen Inc Tratamiento de cancer de mama triple negativo o cancer colorrectal con metastasis hepaticas con un anticuerpo anti-pd-l1 y un virus oncolitico.
EP3941944A4 (en) 2019-03-20 2022-11-30 The Regents of the University of California Claudin-6 bispecific antibodies
DK3941946T3 (da) 2019-03-20 2025-03-24 Univ California Claudin-6-antistoffer og lægemiddelkonjugater
JP2022530241A (ja) 2019-04-30 2022-06-28 インスチトゥート デ メディシーナ モリクラール ジョアン ロボ アントゥネス Cdk阻害剤と組み合わせたrank経路阻害剤
US12558407B2 (en) 2019-05-02 2026-02-24 University Of Florida Research Foundation, Inc. Compositions for treatment of diffuse intrinsic pontine glioma
EP3986441A1 (en) 2019-06-24 2022-04-27 Amgen Inc. Inhibition of sirp-gamma for cancer treatment
FR3140369B1 (fr) 2022-10-04 2025-07-25 Univ Poitiers Procédé de fluoration et/ou cyclisation d’un alcène ou alcyne aminé en flux continu et installation pour la mise en œuvre du procédé

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296418B1 (enExample) * 1974-12-30 1978-07-21 Anvar
US4110330A (en) * 1977-05-27 1978-08-29 Eli Lilly And Company 5'-Acetonylvincristine and related compounds
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4320058A (en) * 1980-12-29 1982-03-16 Eli Lilly And Company 20'-Hydroxyvinblastine and related compounds
HU193772B (en) * 1985-06-12 1987-11-30 Richter Gedeon Vegyeszet Process for producing new nitro-bis-indole derivatives

Also Published As

Publication number Publication date
DK0710240T3 (da) 1997-06-02
FR10C0012I2 (enExample) 2011-04-01
JPH09500634A (ja) 1997-01-21
DE69401216D1 (de) 1997-01-30
DE69401216T2 (de) 1997-07-03
US5620985A (en) 1997-04-15
FR2707988B1 (fr) 1995-10-13
ATE146477T1 (de) 1997-01-15
CA2167694C (fr) 2007-03-06
AU7266694A (en) 1995-02-20
DE122010000012I1 (de) 2010-07-08
NZ269172A (en) 1997-10-24
EP0710240A1 (fr) 1996-05-08
CA2167694A1 (fr) 1995-02-02
JP3606872B2 (ja) 2005-01-05
EP0710240B1 (fr) 1996-12-18
GR3022659T3 (en) 1997-05-31
FR2707988A1 (fr) 1995-01-27
LU91660I2 (fr) 2010-05-10
FR10C0012I1 (enExample) 2010-04-16
NZ328612A (en) 2000-05-26
AU693460B2 (en) 1998-07-02
WO1995003312A1 (fr) 1995-02-02
ES2097659T3 (es) 1997-04-01

Similar Documents

Publication Publication Date Title
BR1100311A (pt) Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
ATE201019T1 (de) 9-deoxotaxan verbindungen
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
TR200001344T2 (tr) Sikline bağlı kinazların aminotiyazol önleyicileri.
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
FR2721608B1 (fr) Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE304543T1 (de) (a)-annelierte pyrrolderivate und deren anwendung in der pharmazie
RU94036761A (ru) Производные галантамина и фармацевтическая композиция
HU9403690D0 (en) Branched-amino-substituted thiazoles, process for their preparation and the pharmaceutical compositions which contan them
BR9807944A (pt) Derivados antimitóticos dos alcalóides da vinca, compostos, processo para preparar os compostos, processo para preparar a 4'-desóki-20', 20'-difluorovinblastina, processo para preparar a 20', 20'-diflúoro-3', 4'-diidrovinorrelbina ou vinflunina, produtos medicinais, e, composição farmacêutica
EA200000847A1 (ru) Противоопухолевые средства
BR9407257A (pt) Composto do tipo bis-naftalimida composição farmacêutica processo para tratamento de um tumor em mamifero uso do composto do tipo bis-naftalimida e processo para a preparação compostos do tipo bis-naftalimida
DE69525327D1 (de) Anthracyclin-derivate
PT98976A (pt) Processo para a preparacao de heteroarilmetilbenzenos
GEP19991780B (en) Use of Pyrrolidine Derivatives for Treating Alcoholism
RU94040719A (ru) 2,3,4,5-тетрагидро-1h-3-бензазепины, фармацевтическая композиция, способ лечения и способ получения
GEP19991535B (en) Process for the Preparation of 7-Hydroxy Taxanes
RU94033096A (ru) Соединение, способ лечения и фармацевтическая композиция
RU94026088A (ru) Способ лечения шока и способ ингибирования продуцирования альфа фактора некроза опухоли
TH19877A (th) อนุพันธ์แอนธราไซคลิโนน
YU5796A (sh) Supstituisani derivati indola, postupak za njihovu izradu, lekovi koji ih sadrže i njihova upotreba
IT1261958B (it) 2-(sostituite immino)-tiazolidine e procedimento per la loro preparazione e loro impiego quali antianginose e/o analgesiche

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
BAP Processing applications according to articles 230 and 231 of law 9.279/96: publication of application for third parties submission of comments
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96